Configuration of a new bioartificial liver support system and in vitro evaluation of its functions

Annals of Clinical and Laboratory Science

Volumn 35, Issue 1, 2005, Pages 7-14

  Chen, Zhong ^a,b   Ding, Yitao ^a   Li, Genxi ^a  

^a NANJING UNIVERSITY   (China)

^b NANTONG UNIVERSITY   (China)

Author keywords

Bioartificial liver; Lidocaine metabolism; Liver transplantation; Porcine hepatocyte culture

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; BILIRUBIN; COLLAGENASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ARTICLE; ARTIFICIAL LIVER; BILIRUBIN BLOOD LEVEL; BIOARTIFICIAL ORGAN; CONTROLLED STUDY; FEMALE; HOLLOW FIBER; IN VITRO STUDY; INOCULATION; LIVER CELL; LIVER FUNCTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SPHEROID CELL;

ANIMALS; CELL CULTURE TECHNIQUES; CELL SURVIVAL; HEPATOCYTES; LIDOCAINE; LIVER, ARTIFICIAL; MODELS, BIOLOGICAL; SWINE;

EID: 15444380609     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Watanabe FD, Mullon CJ, Hewitt WR, Arkadopoulos N, Kahaku E, Eguchi S, Khalili T, Arnaout W, Shackleton CR, Rozga J, Soloman B, Demetriou AA. Clinical experience with a bioartificial liver in the treatment of liver failure: a phase I clinical trial. Ann Surg 1997;225:84-494.
2. Arkadoupoulos N, Rozga J, Demetriou AA. Liver assist system: state of art. Int J Artif Organs 1998;21:781-787.
3. Friedman AL. Why bioartificial liver support remains the Holy Grail. ASAIO J 1998;44:241-243.
4. Cuervas-Mons V, Colas A, Rivera JA, Prados E. In vivo efficacy of a bioartificial liver in improving spontaneous recovery from fulminant hepatic failure: a controlled study in pigs. Transplantation 2000;69:337-344.
5. Sussman NL, Chong MG, Koussayer T, He DE, Shang TA, Whisennand HH, Kelly JH. Reversal of fulminant hepatic failure using an extracorporeal liver assist device. Hepatology 1992;16:60-65.
6. Chen SC, Mullon C, Kahaku E, Watenabe F, Hewitt W, Eguchi S, Middleton Y, Arkadopoulos N, Rozga J, Solomon B, Demetriou AA. Treatment of severe liver failure with a bioartificial liver. Ann NY Acad Sci 1997;831:350-360.
7. Patzer JF, Lopez RC, Zhu Y, Wang ZF, Mazariegos GV, Fung JJ. Bioartificial liver assist devices in support of patients with liver failure. HBPD INT 2002;1:18-25.
8. Gerlach JC. Development of a hybrid liver support system: a review. Int J Artif Organs 1996;19:645-654.
9. McLaughlin BE, Tosone CM, Custer LM, Mullon C. Overview of extracorporeal liver support systems and clinical results. Ann NY Acad Sci 1999;875:310-325.
10. Pahernik SA, Thasler WE, Doser M, Gomez-Lechon MJ, Castell MJ, Planck H, Koebe HG. High density culturing of porcine hepatocytes immobilized on nonwoven polyurethane based biomatrices. Cell Tissues Organs 2001;168:170-177.
11. Miyoshi H, Yanagi K, Fukuda H, Ohshima N. Long-term performance of albumin secretion of hepatocytes cultured in a packed-bed reactor utilizing porous resin. Artif Organs 1996;20:803-807.
12. Arnaout WS, Moscioni AD, Barbour RL, Demetriou AA. Development of bioartificial liver: bilirubin conjugation in Gunn rats. J Surg Res 1990;48:379-382.
13. Fremond B, Malandain C, Guyomard C, Chesne C, Guillouzo A, Campion JP. Correction of bilirubin conjugation in the Gunn rat using hepatocytes immobilized in alginate gel beads as an extracorporeal bioartificial liver. Cell Transplant 1993;2:453-460.
14. Gerlach JC, Encke J, Hole O, Muller C, Ryan CJ, Neuhaus P. Bioreactor for a larger scale hepatocyte in-vitro perfusion. Transplantation 1994;58:984-988.
15. Nyberg SL, Shirabe K, Peshwa MV, Sielaff TD, Crotty PL, Mann HJ, Remmel RP, Payne WB, Hu WS, Ferra FB. Extracorporeal application of a gel-entrapment, bioartificial liver: demonstration of drug metabolism and other biochemical functions. Cell Transplant 1993;2:441-452.
16. Xue YL, Zhao SF, Zhang ZY, Wang YF, Li XJ, Huang XQ, Luo Y, Huang YC, Liu CG. Effects of a bioartificial liver support system on acetaminophen-induced acute liver failure canines. World J Gastroenterol 1999;5:308-311.
17. Chen Z, Ding Y, Zhang H. Cryopreservation of suckling pig hepatocytes. Ann Clin Lab Sci 2001;31:391-398.
18. Chen Z, Ding Y, Zhang H. Morphology, viability and functions of suckling pig hepatocytes cultured in serum-free medium at high density. Dig Surg 2002;19:184-193.
19. Chen Z, Ding Y. In situ recirculating collagenase perfusion method for isolation of pig hepatocytes. Cell Biol 2003;25:124-127.
20. Nagasue N, Yukaya H, Ogawa Y, Kohno H, Nakamura T. Human liver regeneration after major hepatic resection: a study of normal liver and livers with chronic hepatitis and cirrhosis. Ann Surg 1987;206:30-39.
21. Matsmura KN, Guevara GR, Huston H. Hybrid bioartificial liver in hepatic failure: preliminary clinical report. Surgery 1987;101:99-103.
22. Lazar A, Peshwa MV, Wu FJ, Chi CM, Cerra FB, Hu WS. Formation of porcine hepatocyte spheroids for use in a bioartificial liver. Cell Transplant 1995;4:259-268.
23. Matsushita T, Amiot B, Hardin J, Platt JL, Nyberg SL. Membrane pore size impacts performance of a xenogeneic bioartificial liver. Transplantation 2003;76, 1299-1305.
24. Hay PD, Veitch AR, Smith MD, Cousins RB, Gaylor JD. Oxygen transfer in a diffusion-limited hollow fiber bioreactor liver. Artif Organs, 2000;24:278-288.
25. Iwata H, Sajiki T, Maeda H, Park YG, Zhu B, Satoh S, Uesugi T, Ikai I, Yamaoka Y, Ikada Y. In vitro evaluation of metabolic functions of a bioartificial liver. ASAIO J, 1999;45:299-306.
26. Thomson AH, Elliot HL, Kelman AW, Meredith PA, Whiting B. The pharmacokinetics and pharmacodynamics of lignocaine and MEGX in healthy subjects. J Pharmacokinet Biopharm 1987;15:101-115.
27. Conti F, Dousset B, Cherruau B, Guérin C, Soubrane O, Houssin D, Calmus Y. Use of lidocaine metabolism to test liver function during the long-term follow-up of liver transplant recipients. Clin Transplant 2004;18:235-241.